Key result
Maternal glucolipotoxicity exposure in rats led to age- and sex-specific declines in cardiac function in aged offspring, driven by impaired oxidative phosphorylation and mitochondrial dysfunction.
Why the study?
Infants of diabetic mothers are at risk of cardiomyopathy at birth and myocardial infarction in adulthood, but prevention is hindered because underlying mechanisms remain unknown.
Maternal glucolipotoxicity programs age- and sex-specific mitochondrial dysfunction and cardiac decline in adult offspring, highlighting mechanisms for developmentally programmed adult heart disease.
May signal intergenerational cardiac vulnerability from maternal metabolic stress; hypothesis-generating for human developmental origins research.
Infants of diabetic mothers are at risk of cardiomyopathy at birth and myocardial infarction in adulthood, but prevention is hindered because mechanisms remain unknown. We previously showed that maternal glucolipotoxicity increases the risk of cardiomyopathy and mortality in newborn rats through fuel-mediated mitochondrial dysfunction. Here we demonstrate ongoing cardiometabolic consequences by cross-fostering and following echocardiography, cardiomyocyte bioenergetics, mitochondria-mediated turnover, and cell death following metabolic stress in aged adults. Like humans, cardiac function improves by weaning with no apparent differences in early adulthood but declines again in aged diabetes-exposed offspring. This is preceded by impaired oxidative phosphorylation, exaggerated age-related increase in mitochondrial number, and higher oxygen consumption. Prenatally exposed male cardiomyocytes have more mitolysosomes indicating high baseline turnover; when exposed to metabolic stress, mitophagy cannot increase and cardiomyocytes have faster mitochondrial membrane potential loss and mitochondria-mediated cell death. Details highlight age- and sex-specific roles of mitochondria in developmentally programmed adult heart disease.
No takes yet. Share an insight, caveat, or question.
Louwagie et al. (2020) studied Cardiomyopathy risk from maternal glucolipotoxicity. Maternal glucolipotoxicity vs. Unexposed offspring was evaluated on Cardiac function, cardiomyocyte bioenergetics, and mitochondria-mediated turnover. Maternal glucolipotoxicity exposure in rats led to age- and sex-specific declines in cardiac function in aged offspring, driven by impaired oxidative phosphorylation and mitochondrial dysfunction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: